Resverlogix Provides Update on BETonMACE Phase 3 Trial

NEXT STORY
Peer-Reviewed Journal Future Oncology Publishes Two Manuscripts on Cancer Metabolism and Drug Candidate CPI-613® (Devimistat)
PREV STORY
Auransa to Present New Data on AU-409, a Novel, AI-Generated Drug Candidate for the Treatment of Hepatocellular Carcinoma, at the 13th Annual Conference of the International Liver Cancer Association
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Check-Cap Announces Presentation on Feasibility of Prepless CRC Screening at Digestive Disease Week 2018

ISFIYA, ISRAEL, June 02, 2018 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (the “Company” or “Check-Cap”) ...

author_avatar
NASDAQ Market News

Loxo Oncology Announces Second Quarter 2017 Financial Results

– Larotrectinib NDA Submission on Track for Year End 2017 / Early 2018 – ...

author_avatar
NASDAQ Market News

Sunesis Announces Proposed Public Offering of Common Stock, Preferred Stock and Warrants

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) ...

author_avatar
NASDAQ Market News